Parkside Financial Bank & Trust United Therapeutics Corp Transaction History
Parkside Financial Bank & Trust
- $742 Million
- Q4 2024
A detailed history of Parkside Financial Bank & Trust transactions in United Therapeutics Corp stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 70 shares of UTHR stock, worth $24,339. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70
Previous 67
4.48%
Holding current value
$24,339
Previous $24,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding UTHR
# of Institutions
692Shares Held
60.6MCall Options Held
194KPut Options Held
298K-
Wealthfront Advisers LLC18.3MShares$6.37 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.9 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.53 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.1 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$994 Million15.42% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $15.8B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...